Skip to main content

All Publications

Michael Chuong, Miami Cancer InstituteFollow

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial

Publication Date

9-1-2022

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

JAMA Oncol (2022) 8(9):1263-1270

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS